A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711
NCT04135820
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
NSCLC
Interventions
DRUG:
BPI-7711
Sponsor
Beta Pharma, Inc.